CD10 - A review

被引:78
|
作者
Arber, DA
Weiss, LM
机构
[1] Division of Pathology, City of Hope National Medical Center, Duarte, CA
[2] Division of Pathology, City of Hope National Medical Center, Duarte, CA 91010
关键词
CD10; CALLA; neutral endopeptidase 24.11; acute lymphoblastic leukemia; lymphoblastic lymphoma; follicular lymphoma; Burkitt's lymphoma;
D O I
10.1097/00022744-199709000-00001
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
The antigen defined by the cluster designation group 10 (CD 10) has also been called common acute lymphoblastic leukemia antigen (CALLA) and neutral endopeptidase (NEP). This antigen is expressed by a variety of normal cell types, including lymphoid precursor cells, germinal center B lymphocytes, and some epithelial cells. On the cell surface, CD10 is an enzyme that functions to reduce the cellular response to peptide hormones. On neoplastic cells, the antigen is detected in a high percentage of cases of acute lymphoblastic leukemia (ALL), follicular lymphoma, Burkitt's lymphoma, and some nonhematopoietic tumors. CD10 is not a lineage-specific antigen, but its detection may be of value in combination with other antibodies. The detection of this antigen is most valuable in the diagnosis and classification of lymphoblastic malignancies, follicular lymphomas, and Burkitt's lymphoma.
引用
收藏
页码:125 / 140
页数:16
相关论文
共 50 条
  • [21] CD10 expression and survival - The authors' reply
    Urherova, P
    Ross, CW
    Schnitzer, B
    Finn, WG
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2002, 117 (04) : 661 - 662
  • [22] CD10, a useful marker for atypical fibroxanthomas
    Weedon, D
    Williamson, R
    Mirza, B
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2005, 27 (02) : 181 - 181
  • [23] CD10 expression in urothelial carcinoma of the bladder
    Burak Bahadir
    Kemal Behzatoglu
    Sibel Bektas
    Erol R Bozkurt
    Sukru O Ozdamar
    Diagnostic Pathology, 4
  • [24] CD10 expression in urothelial carcinoma of the bladder
    Bahadir, Burak
    Behzatoglu, Kemal
    Bektas, Sibel
    Bozkurt, Erol R.
    Ozdamar, Sukru O.
    DIAGNOSTIC PATHOLOGY, 2009, 4
  • [25] Availability of CD10 as a histopathological diagnostic marker
    Yasuda, M
    Itoh, J
    Satoh, Y
    Kumaki, N
    Tsukinoki, K
    Ogane, N
    Osamura, RY
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 2005, 38 (01) : 17 - 24
  • [26] THE ROLE OF CD10 IN THE DIAGNOSIS OF ATYPICAL FIBROXANTHOMA
    Wieland, C.
    Gibson, L.
    Wada, D.
    Comfere, N.
    Weenig, R.
    Dyck, R.
    Weed, B.
    Kortuem, K.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2009, 36 (01) : 170 - 170
  • [27] Immunoexpression of BRAF, EGFR and CD10 in ameloblastoma
    Tan, Chuey Chuan
    Siar, Chong Huat
    Shanmuhasuntharam, Palasuntharam
    MALAYSIAN JOURNAL OF PATHOLOGY, 2022, 44 (01) : 19 - 28
  • [28] E-Cadherin/β-Catenin and CD10
    Burford, Holly
    Baloch, Zubair
    Liu, Xiuli
    Jhala, Darshana
    Siegal, Gene P.
    Jhala, Nirag
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 132 (06) : 831 - 839
  • [29] CD10 positivity in breast epithelial neoplasms
    Bains, Amanpreet S.
    Sidhu, Jagmohan S.
    JOURNAL OF CLINICAL PATHOLOGY, 2007, 60 (08) : 958 - 959
  • [30] CD10 expression in cycling endometrium and decidua
    Yamasaki, F
    Tungsinmunkong, K
    Ioffe, OB
    Silverberg, SG
    LABORATORY INVESTIGATION, 2003, 83 (01) : 215A - 216A